Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Tamil Nadu Petro Products Ltd

TNPETRO
NSE
87.90
2.24%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Tamil Nadu Petro Products Ltd

TNPETRO
NSE
87.90
2.24%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
791Cr
Close
Close Price
87.90
Industry
Industry
Petrochem - Others
PE
Price To Earnings
6.80
PS
Price To Sales
0.44
Revenue
Revenue
1,796Cr
Rev Gr TTM
Revenue Growth TTM
-0.73%
PAT Gr TTM
PAT Growth TTM
165.65%
Peer Comparison
How does TNPETRO stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
TNPETRO
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
480451434346438462450460455463457421
Growth YoY
Revenue Growth YoY%
10.3-18.9-28.2-32.3-8.82.43.633.13.90.21.7-8.5
Expenses
ExpensesCr
467431414326426450442442429416416390
Operating Profit
Operating ProfitCr
13202020121271926474131
OPM
OPM%
2.84.54.65.82.72.51.64.05.710.29.07.4
Other Income
Other IncomeCr
979-6121676187138
Interest Expense
Interest ExpenseCr
221221222137
Depreciation
DepreciationCr
655666666666
PBT
PBTCr
1421236152061636474526
Tax
TaxCr
35613514912116
PAT
PATCr
1115185121551227353420
Growth YoY
PAT Growth YoY%
-55.1-46.5-36.1-82.79.6-2.4-73.5157.7118.7134.2625.469.9
NPM
NPM%
2.33.44.11.32.83.31.12.55.97.67.54.7
EPS
EPS
1.31.72.00.51.41.70.51.33.03.93.82.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
9507018891,0491,2451,2251,1451,8062,1501,6691,8271,796
Growth
Revenue Growth%
-9.7-26.226.918.018.7-1.6-6.557.719.1-22.49.5-1.7
Expenses
ExpensesCr
9766968259611,1541,1329811,5582,0231,5971,7631,651
Operating Profit
Operating ProfitCr
-264648891931652481287263146
OPM
OPM%
-2.80.67.28.37.37.614.413.75.94.33.58.1
Other Income
Other IncomeCr
136532191017401825234747
Interest Expense
Interest ExpenseCr
20153410797677613
Depreciation
DepreciationCr
211816222022232421232525
PBT
PBTCr
-5437467475791752361246579155
Tax
TaxCr
-18032251716486130152038
PAT
PATCr
-363713485763126175945058116
Growth
PAT Growth%
-17.7203.1-63.6259.518.011.099.439.0-46.3-46.816.699.2
NPM
NPM%
-3.85.31.54.64.65.211.09.74.43.03.26.5
EPS
EPS
-4.74.11.55.96.37.014.019.510.55.66.512.9

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
909090909090909090909090
Reserves
ReservesCr
175212224272335392501658731769822887
Current Liabilities
Current LiabilitiesCr
314179148155155142143155200149250385
Non Current Liabilities
Non Current LiabilitiesCr
1586286495160788182193225
Total Liabilities
Total LiabilitiesCr
5944895246036296747949811,1021,0911,3541,587
Current Assets
Current AssetsCr
284231277365368358489660726683586713
Non Current Assets
Non Current AssetsCr
311258248238261316305321376407768873
Total Assets
Total AssetsCr
5944895246036296747949811,1021,0911,3541,587

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
3473468678869311287161207
Investing Cash Flow
Investing Cash FlowCr
4316-19-68-61-48-87-96-58-70-244
Financing Cash Flow
Financing Cash FlowCr
-76-50-29-16-8-23-4-22-12-78100
Net Cash Flow
Net Cash FlowCr
139-228141-6171363
Free Cash Flow
Free Cash FlowCr
34932762352283725122-180
CFO To PAT
CFO To PAT%
-94.9197.8343.8177.6136.9135.573.363.792.7322.1354.1
CFO To EBITDA
CFO To EBITDA%
-128.31,738.272.698.185.692.456.245.168.5223.9325.7

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1281813324453162224391,028640703621
Price To Earnings
Price To Earnings
0.04.924.88.35.53.53.55.96.814.010.6
Price To Sales
Price To Sales
0.10.30.40.40.30.20.40.60.30.40.3
Price To Book
Price To Book
0.50.61.11.20.70.50.71.40.80.80.7
EV To EBITDA
EV To EBITDA
-5.630.54.13.61.70.51.12.92.74.16.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.838.542.146.244.746.456.853.141.841.639.5
OPM
OPM%
-2.80.67.28.37.37.614.413.75.94.33.5
NPM
NPM%
-3.85.31.54.64.65.211.09.74.43.03.2
ROCE
ROCE%
-9.514.222.621.117.517.028.330.114.68.28.1
ROE
ROE%
-13.512.24.313.313.413.121.423.411.55.86.4
ROA
ROA%
-6.07.52.68.09.19.415.917.98.64.64.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Overview** **Tamil Nadu Petro Products Limited (TPL)**, established in 1984, is a leading Indian manufacturer of industrial intermediate chemicals. Headquartered in Chennai, the company has grown into a key player in the Indian petrochemicals and FMCG input sectors. TPL operates five manufacturing facilities across India—from Baddi in the North to Tuticorin in the South—and maintains a dominant market presence, especially in South India, where it holds **over 85% market share by turnover** in the detergents and dishwashing FMCG categories. TPL is vertically integrated with a diversified product portfolio centered on four core segments: - **Linear Alkyl Benzene (LAB)** – marketed under the brand *Superlab®* - **Caustic Soda** (and its flake variant) - **Chlorine** – a co-product of caustic soda production - **Propylene Oxide (PO)** – introduced in 2018–19 via conversion of its former ECH unit The company also owns two foreign subsidiaries: **Certus Investment and Trading Limited (Mauritius)** and its step-down entity **Certus Investment and Trading (S) Private Limited (Singapore)**, likely used for international investment and trade facilitation. --- ### **Key Products and Applications** #### **1. Linear Alkyl Benzene (LAB)** - **Primary Product & Major Profit Driver**: LAB remains TPL’s most significant revenue and profit contributor. - **Uses**: Mainly in **domestic, institutional, and industrial detergents**. Also used in specialty applications such as **cable oil, ink, paint, and insulation**. - **Brand**: Marketed as *Superlab®*, sold to detergent manufacturers and sulphonators across India. - **Market Position**: TPL is a **dominant player in the Indian LAB market**, with strong relationships with major FMCG clients including **HUL, P&G, and Jyothy Labs**. - **Export Strategy**: Currently, all LAB production is consumed domestically due to high local demand, but **post-capacity expansion**, the company plans to **pursue export opportunities**. #### **2. Caustic Soda and Chlorine** - **Production Synergy**: Caustic soda is produced via chlor-alkali electrolysis, with chlorine generated as a co-product. - **Caustic Soda Uses**: Key input for **textiles, pulp & paper, aluminium, soaps, and detergents**. - **Chlorine Uses**: Supplied to industries producing **vinyl chloride, chlorinated paraffins, water purification chemicals, and solvents**. - **Strategic Focus**: TPL is **revamping and expanding its chlor-alkali (HCD) unit** using **energy-efficient bipolar electrolysers**, aimed at reducing variable costs and increasing capacity to **82,500 tonnes per annum**. #### **3. Propylene Oxide (PO)** - **Production Start**: 2018–19; produced via **chlorohydrin or epoxidation processes**. - **Applications**: Feedstock for **polyether polyols** (used in polyurethane foams), adhesives, coatings, and propylene glycol. - **Market Context**: India imports **35,000–40,000 MT/year** of PO, primarily from Thailand, Singapore, and Saudi Arabia, due to **cheaper global prices**. - **Sales Model**: TPL has full off-take arrangements, but production is linked to recovery in **end-user sectors like automotive**. #### **4. Propylene Recovery Unit (PRU) – Strategic Future Initiative** - **First-of-its-kind in India** by a private non-refining company. - **Investment**: ~₹30 crore; largely funded internally. - **Objective**: To derive **propylene from LPG** as a feedstock for PO production, reducing dependence on external sourcing. - **Status (as of Mar 2021)**: In-house R&D completed; implementation expected within 12–18 months post-approvals. --- ### **Recent Developments & Strategic Initiatives (2023–2025)** #### **Capacity Expansion & Revamping** - **LAB Plant Revamp (Ongoing in Sep 2025)**: - Target capacity: **145,000 tonnes per annum (KTPA)**. - Objective: Increase domestic market share and enable **exports post-completion**. - Expected to boost **capacity utilization, margins, and competitiveness**. - **HCD Unit Revamp**: - Upgrade includes **bipolar electrolysers** for energy efficiency. - Capacity to increase to **82,500 TPA** of caustic soda. - Aims to reduce per-unit production costs and improve sustainability. #### **Market Trends & Demand Dynamics** - **Shift in Detergent Formulations**: - Consumer shift from **powder to liquid detergents** is increasing demand for **LABSA 96%**, a key raw material. - Despite lower LABSA intensity per unit, rising volumes are driving overall demand growth. - **Elevated LAB Prices (Aug 2025)**: - Driven by **strong FMCG demand**, global supply constraints, and **geopolitical tensions/trade barriers**. - TPL benefited from **competitor plant turnarounds**, leading to improved net realizations. - **Crude Oil & Feedstock Costs**: - Strategic benzene procurement amid **crude oil price decline** (from $85+ to ~$70/bbl) improved margins. - However, **Normal Paraffin sourcing** remains challenging due to **price volatility**. - **Caustic Soda Price Volatility**: - Prices declined in early 2025 due to weak demand but **surged in H2** due to **Chinese supply disruptions**. - Global overcapacity (from China and Europe) continues to pressure lyes pricing. #### **Diversification & Risk Mitigation** - **Exploring Chlorine Derivatives**: To reduce exposure to chlorine market fluctuations through higher-value derivative sales. - **Expanding By-product Sales**: Enhancing profitability via better utilization of co-products. - **New LAB Applications**: - Developing sales in **non-detergent sectors** like **crop protection chemicals and EOR (Enhanced Oil Recovery) polymers**. - A dedicated sales channel established for these specialty applications. - **Long-Term Contracts**: Signed with major FMCGs (HUL, P&G, Jyothy) to **stabilize demand** and reduce exposure to spot price volatility. #### **Competitive Landscape & Risks** - **Import Threats**: - **LAB, caustic soda, and indirect chlorine imports** pose significant risks. - **New Saudi capacity (120,000 TPA in Yanbu)** may flood Indian markets and depress prices. - **Anti-dumping duties on LAB lapsed in April 2022**, reducing pricing power. - **Domestic Competition**: - **IOCL expansion and new entrant Farabi** are expected to increase competition. - **Cost Disadvantages**: Indian producers face **higher energy and feedstock costs** vs. Middle East competitors. #### **Sustainability & Innovation** - **BIS Certification (Mar 2022)**: TPL became the **first global LAB manufacturer to receive BIS certification**, offering a potential quality-based advantage. - However, **delayed enforcement** in India allows sub-standard imports. - **Energy Optimization**: Ongoing initiatives in utility efficiency, procurement timing, and process integration to improve margins. --- ### **Future Roadmap (Nov 2025 View)** | Initiative | Status | Target Outcome | |---------|--------|----------------| | **LAB Capacity to 145 KTPA** | Revamp ongoing | Boost domestic market share, enable exports | | **HCD Unit Modernization** | In advanced stages | Higher output, lower energy costs | | **Caustic Soda Flakes Restart** | Planned post-revamp | Revenue diversification | | **Propylene Recovery Unit (PRU)** | Awaiting approvals (since 2021) | Reduce feedstock costs, enhance self-sufficiency | | **Diversify into Non-Detergent LAB Applications** | Active | New revenue streams, reduced segment concentration | | **Expand By-product Sales / Chlorine Derivatives** | Under exploration | Margin enhancement, risk mitigation | ---